Revvity Cost of Goods Sold 2010-2024 | RVTY

Revvity annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Revvity cost of goods sold for the quarter ending September 30, 2024 was $0.299B, a 0.34% increase year-over-year.
  • Revvity cost of goods sold for the twelve months ending September 30, 2024 was $1.213B, a 0.78% increase year-over-year.
  • Revvity annual cost of goods sold for 2023 was $1.211B, a 8.4% decline from 2022.
  • Revvity annual cost of goods sold for 2022 was $1.322B, a 5.15% decline from 2021.
  • Revvity annual cost of goods sold for 2021 was $1.394B, a 49.38% increase from 2020.
Revvity Annual Cost of Goods Sold
(Millions of US $)
2023 $1,211
2022 $1,322
2021 $1,394
2020 $933
2019 $1,488
2018 $1,437
2017 $1,183
2016 $1,101
2015 $1,141
2014 $1,135
2013 $1,181
2012 $1,144
2011 $1,071
2010 $943
2009 $850
Revvity Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $299
2024-06-30 $306
2024-03-31 $295
2023-12-31 $312
2023-09-30 $298
2023-06-30 $307
2023-03-31 $293
2022-12-31 $305
2022-09-30 $305
2022-06-30 $344
2022-03-31 $368
2021-12-31 $-10
2021-09-30 $338
2021-06-30 $543
2021-03-31 $523
2020-12-31 $-212
2020-09-30 $437
2020-06-30 $364
2020-03-31 $344
2019-12-31 $407
2019-09-30 $365
2019-06-30 $375
2019-03-31 $341
2018-12-31 $380
2018-09-30 $342
2018-06-30 $363
2018-03-31 $352
2017-12-31 $334
2017-09-30 $285
2017-06-30 $289
2017-03-31 $274
2016-12-31 $290
2016-09-30 $266
2016-06-30 $283
2016-03-31 $263
2015-12-31 $229
2015-09-30 $309
2015-06-30 $311
2015-03-31 $292
2014-12-31 $233
2014-09-30 $299
2014-06-30 $308
2014-03-31 $295
2013-12-31 $313
2013-09-30 $289
2013-06-30 $299
2013-03-31 $280
2012-12-31 $303
2012-09-30 $279
2012-06-30 $283
2012-03-31 $279
2011-12-31 $300
2011-09-30 $254
2011-06-30 $270
2011-03-31 $247
2010-12-31 $259
2010-09-30 $233
2010-06-30 $232
2010-03-31 $218
2009-12-31 $144
2009-09-30 $208
2009-06-30 $250
2009-03-31 $247
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00